Beacon Investment Advisory Services’s Tandem Diabetes Care TNDM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-240	Closed	-$4.6K	–	846
2026 Q1	$4.6K	Buy	+240	New	+$5.21K	﹤0.01%	703
2025 Q1	–	Sell	-18,905	Closed	-$681K	–	252
2024 Q4	$681K	Sell	18,905 -13,705	-42%	-$464K	0.03%	154
2024 Q3	$1.38M	Sell	32,610 -970	-3%	-$41.1K	0.06%	129
2024 Q2	$1.35M	Sell	33,580 -2,883	-8%	-$120K	0.06%	126
2024 Q1	$1.29M	Sell	36,463 -1,467	-4%	-$39.3K	0.06%	126
2023 Q4	$1.12M	Sell	37,930 -4,031	-10%	-$83.6K	0.05%	134
2023 Q3	$872K	Sell	41,961 -779	-2%	-$21.4K	0.04%	153
2023 Q2	$1.05M	Buy	42,740 +17,326	+68%	+$557K	0.05%	152
2023 Q1	$1.03M	Sell	25,414 -3,710	-13%	-$154K	0.05%	147
2022 Q4	$1.31M	Buy	29,124 +2,215	+8%	+$100K	0.07%	136
2022 Q3	$1.29M	Buy	26,909 +4,359	+19%	+$239K	0.07%	134
2022 Q2	$1.33M	Buy	22,550 +1,126	+5%	+$92.4K	0.07%	137
2022 Q1	$2.49M	Buy	21,424 +1,622	+8%	+$189K	0.11%	121
2021 Q4	$2.98M	Buy	19,802 +1,618	+9%	+$218K	0.12%	121
2021 Q3	$2.17M	Buy	18,184 +3,568	+24%	+$393K	0.09%	130
2021 Q2	$1.42M	Buy	14,616 +1,725	+13%	+$154K	0.06%	151
2021 Q1	$1.14M	Buy	12,891 +3,487	+37%	+$324K	0.05%	156
2020 Q4	$900K	Buy	9,404 +3,092	+49%	+$319K	0.04%	155
2020 Q3	$716K	Buy	6,312 +407	+7%	+$42.8K	0.04%	154
2020 Q2	$584K	Buy	5,905 +1,509	+34%	+$120K	0.03%	160
2020 Q1	$283K	Buy	+4,396	New	+$308K	0.02%	199